https://journals.lww.com/jasn/abstract/10.1681/asn.0000001162~evaluating-barriers-to-kidney-transplantation-in-the-united?redirectionsource=fulltextview (https://journals.lww.com/jasn/abstract/10.1681/asn.0000001162~evaluating-barriers-to-kidney-transplantation-in-the-united?redirectionsource=fulltextview)
Evaluating Barriers to Kidney Transplantation in the United States
- Conor B. Donnelly, et al.
Journal of the American Society of Nephrology
Publish Ahead of Print, June 20, 2026.
DOI: 10.1681/ASN.0000001162
Abstract
Key Points
- In this cohort study of 720,348 adults referred for kidney transplantation from 2014 to 2025, only 48% were evaluated and 19% were waitlisted.
- Progression from referral to evaluation, waitlisting, and kidney transplantation was limited by individual, center-level, and geographic factors.
- Some centers evaluated and waitlisted patients at rates far below the national average, and low-volume centers had lower rates of transplantation.
Background
Kidney transplantation is a cost-effective, lifesaving treatment of kidney failure, compared with dialysis. Unfortunately, most patients with kidney failure never undergo transplantation.
Methods
Using Epic Cosmos electronic health record data on all patients referred for kidney transplantation from 2014 to 2025, we assessed the stage-specific progression and attrition in the process of evaluation, waitlisting, and kidney transplantation. Center-level and individual (socioeconomic, geographic, and insurance status) factors associated with access to evaluation, waitlisting, and kidney transplantation were characterized using modified Poisson regression.
Results
Among 720,348 referred candidates, the median age was 55 years (interquartile range [IQR], 42–64); 47% of patients were White, 52% were male, and 87% were English speaking. Eighty-five percent of patients lived in urban areas. Of the referred candidates, 48% initiated evaluation, 19% were waitlisted, and 10% ultimately underwent transplantation. Among the referred patients who initiated evaluation, the median (IQR) time to evaluation initiation was 2 (1–4) months after referral; among the patients who were waitlisted, the median (IQR) time to waitlisting was 4 (2–9) months after evaluation initiation. Patients who were never married (adjusted relative risk, 0.94; 95% confidence interval [CI], 0.93 to 0.94), had severe obesity (0.70; 95% CI, 0.69 to 0.72), or were from rural zip codes (0.98; 95% CI, 0.97 to 1.00) were less likely to initiate evaluation. Low-volume centers had lower relative rates of transplantation (adjusted hazard ratio, 0.92; 95% CI, 0.88 to 0.96). In centers with documentation for nonprogression to evaluation, reasons for removal included not meeting criteria/not a candidate (18%), patient decision (13%), unable to contact (12%), death (4%), and financial/insurance complications (7%).
Conclusions
Our study shows substantial attrition before kidney transplant waitlisting.